Longitudinal change of small-vessel disease-related brain abnormalities

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 1, 2016, Pages 26-39

  Schmidt, Reinhold ^a   Seiler, Stephan ^a   Loitfelder, Marisa ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

lacunes; microbleeds; normal appearing brain tissue; small vessel disease; white matter lesions

Indexed keywords

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN HEMORRHAGE; BRAIN SIZE; BRAIN TISSUE; CADASIL; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE MARKER; EXECUTIVE FUNCTION; HUMAN; LACUNES; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER LESION; BRAIN; LACUNAR STROKE; MICROVASCULATURE; PATHOLOGY; TIME FACTOR; VASCULARIZATION; WHITE MATTER;

BRAIN; CEREBRAL HEMORRHAGE; CEREBRAL SMALL VESSEL DISEASES; DEMENTIA, VASCULAR; HUMANS; MAGNETIC RESONANCE IMAGING; MICROVESSELS; STROKE, LACUNAR; TIME FACTORS; WHITE MATTER;

EID: 84951569037     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2015.72     Document Type: Review

References (90)

1. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010; 9: 689-701
2. Schmidt R, Schmidt H, Haybaeck J, Loitfelder M, Weis S, Cavalieri M, et al. Heterogeneity in age-related white matter changes. Acta Neuropathol 2011; 122: 171-185
3. Cavalieri M, Schmidt H and Schmidt R. Structural MRI in normal aging and Alzheimer's disease: white and black spots. Neurodegener Dis 2012; 10: 253-256
4. Poggesi A, Pantoni L, Inzitari D, Fazekas F, Ferro J, O'Brien J, et al. The LADIS Study Group. 2001-2011: a decade of the LADIS (Leukoaraiosis And DISability) Study: what have we learned about white matter changes and small-vessel disease? Cerebrovasc Dis 2011; 32: 577-588
5. Graham SJ and Henkelman RM. Understanding pulsed magnetization transfer. J Magn Reson Imaging 1997; 7: 903-912
6. Mori S and Zhang J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 2006; 51: 527-539
7. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, et al. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 2004; 63: 139-144
8. Wahlund LO, Almkvist O, Basun H and Julin P. MRI in successful aging, a 5-year follow-up study from the eighth to ninth decade of life. Magn Reson Imaging 1996; 14: 601-608
9. Veldink JH, Scheltens P, Jonker C and Launer LJ. Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology 1998; 51: 319-320
10. Taylor WD, MacFall JR, Provenzale JM, Payne ME, McQuoid DR, Steffens DC, et al. Serial MR imaging of volumes of hyperintense white matter lesions in elderly patients: correlation with vascular risk factors. AJR Am J Roentgenol 2003; 181: 571-576
11. ten Dam VH, van den Heuvel DMJ, van Buchem MA, Westendorp RGJ, Bollen ELEM, Ford I, et al. Effect of pravastatin on cerebral infarcts and white matter lesions. Neurology 2005; 64: 1807-1809
12. Gouw AA, van der Flier WM, Fazekas F, van Straaten ECW, Pantoni L, Poggesi A, et al. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study. Stroke 2008; 39: 1414-1420
13. Maillard P, Crivello F, Dufouil C, Tzourio-Mazoyer N, Tzourio C and Mazoyer B. Longitudinal follow-up of individual white matter hyperintensities in a large cohort of elderly. Neuroradiology 2009; 51: 209-220
14. Gottesman RF, Coresh J, Catellier DJ, Sharrett AR, Rose KM, Coker LH, et al. Blood pressure and whitematter disease progression in a biethnic cohort: Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010; 41: 3-8
15. Lo RY and Jagust WJ. Vascular burden and Alzheimer disease pathologic progression. Neurology 2012; 79: 1349-1355
16. Maillard P, Carmichael O, Harvey D, Fletcher E, Reed B, Mungas D, et al. FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR Am J Neuroradiol 2013; 34: 54-61
17. Kaffashian S, Tzourio C, SoumaréA, Dufouil C, Zhu Y, Crivello F, et al. Plasma b-amyloid and MRI markers of cerebral small vessel disease: Three-City Dijon study. Neurology 2014; 83: 2038-2045
18. Peng J, Lu F, Wang Z, Zhong M, Sun L, Hu N, et al. Excessive lowering of blood pressure is not beneficial for progression of brain white matter hyperintensive and cognitive impairment in elderly hypertensive patients: 4-year follow-up study. J Am Med Dir Assoc 2014; 15: 904-910
19. Erdélyi-Bótor S, Aradi M, Kamson DO, Kovács N, Perlaki G, Orsi G, et al. Changes of migraine-related white matter hyperintensities after 3 years: a longitudinal MRI study. Headache 2015; 55: 55-70
20. Brickman AM, Zahodne LB, Guzman VA, Narkhede A, Meier IB, Griffith EY, et al. Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol Aging 2015; 36: 27-32
21. Whitman GT, Tang Y, Lin A, Baloh RW and Tang T. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001; 57: 990-994
22. Schmidt R, Enzinger C, Ropele S, Schmidt H and Fazekas F. Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003; 361: 2046-2048
23. Garde E, Lykke Mortensen E, Rostrup E and Paulson OB. Decline in intelligence is associated with progression in white matter hyperintensity volume. J Neurol Neurosurg Psychiatry 2005; 76: 1289-1291
24. Longstreth WT, Arnold AM, Beauchamp NJ, Manolio TA, Lefkowitz D, Jungreis C, et al. Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2005; 36: 56-61
25. Sachdev P, Wen W, Chen X and Brodaty H. Progression of white matter hyperintensities in elderly individuals over 3 years. Neurology 2007; 68: 214-222
26. van Dijk EJ, Prins ND, Vrooman HA, Hofman A, Koudstaal PJ and Breteler MMB. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 2008; 39: 2712-2719
27. van den Heuvel DMJ, ten Dam VH, de Craen AJM, Admiraal-Behloul F, Olofsen H, Bollen ELEM, et al. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a nondemented elderly population. J Neurol Neurosurg Psychiatry 2006; 77: 149-153
28. Holtmannspötter M, Peters N, Opherk C, Martin D, Herzog J, Brückmann H, et al. Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke 2005; 36: 2559-2565
29. Maillard P, Carmichael O, Fletcher E, Reed B, Mungas D and De Carli C. Coevolution of white matter hyperintensities and cognition in the elderly. Neurology 2012; 79: 442-448
30. Duering M, Csanadi E, Gesierich B, Jouvent E, HervéD, Seiler S, et al. Incident lacunes preferentially localize to the edge of white matter hyperintensities: insights into the pathophysiology of cerebral small vessel disease. Brain 2013; 136: 2717-2726
31. Schmidt R, Fazekas F, Enzinger C, Ropele S, Kapeller P and Schmidt H. Risk factors and progression of small vessel disease-related cerebral abnormalities. J Neural Transm Suppl 2002; 62: 47-52
32. Schmidt R, Fazekas F, Kapeller P, Schmidt H and Hartung HP. MRI white matter hyperintensities: threeyear follow-up of the Austrian Stroke Prevention Study. Neurology 1999; 53: 132-139
33. Verhaaren BFJ, Vernooij MW, de Boer R, Hofman A, Niessen WJ, van der Lugt A, et al. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension 2013; 61: 1354-1359
34. Godin O, Tzourio C, Maillard P, Mazoyer B and Dufouil C. Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation 2011; 123: 266-273
35. Kloppenborg RP, Geerlings MI, Visseren FL, Mali WPTM, Vermeulen M, van der Graaf Y, et al. Homocysteine and progression of generalized smallvessel disease: the SMART-MR Study. Neurology 2014; 82: 777-783
36. Godin O, Tzourio C, Maillard P, Alpérovitch A, Mazoyer B and Dufouil C. Apolipoprotein E genotype is related to progression of white matter lesion load. Stroke 2009; 40: 3186-3190
37. Schmidt R, Schmidt H, Fazekas F, Kapeller P, Roob G, Lechner A, et al. MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: three-year follow-up of the austrian stroke prevention study. Arterioscler Thromb Vasc Biol 2000; 20: 1811-1816
38. Schmidt H, Zeginigg M, Wiltgen M, Freudenberger P, Petrovic K, Cavalieri M, et al. Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain 2011; 134: 3384-3397
39. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005; 58: 610-616
40. Kramer JH, Mungas D, Reed BR, Wetzel ME, Burnett MM, Miller BL, et al. Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology 2007; 21: 412-418
41. Silbert LC, Nelson C, Howieson DB, Moore MM and Kaye JA. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline. Neurology 2008; 71: 108-113
42. Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Preboske GM, Kantarci K, et al. Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain 2015; 138: 761-771
43. Kloppenborg RP and Nederkoorn PJ. Presence and progression of white matter hyperintensities and cognition: a meta analysis. Neurology 2014; 82: 2127-2138
44. Garde E, Mortensen EL, Krabbe K, Rostrup E and Larsson HB. Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet 2000; 356: 628-634
45. Firbank MJ, Teodorczuk A, van der Flier WM, Gouw AA, Wallin A, Erkinjuntti T, et al. Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study. Br J Psychiatry 2012; 201: 40-45
46. Smith EE, Egorova S, Blacker D, Killiany RJ, Muzikansky A, Dickerson BC, et al. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008; 65: 94-100
47. Van Straaten ECW, Harvey D, Scheltens P, Barkhof F, Petersen RC, Thal LJ, et al. Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia. J Neurol 2008; 255: 1302-1308
48. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009; 339: b2477
49. Prins ND, van Straaten ECW, van Dijk EJ, Simoni M, van Schijndel RA, Vrooman HA, et al. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 2004; 62: 1533-1539
50. Schmidt R, Berghold A, Jokinen H, Gouw AA, van der Flier WM, Barkhof F, et al. White matter lesion progression in LADIS: frequency, clinical effects, and sample size calculations. Stroke 2012; 43: 2643-2647
51. Schmidt R, Petrovic K, Ropele S, Enzinger C and Fazekas F. Progression of leukoaraiosis and cognition. Stroke 2007; 38: 2619-2625
52. Ferris SH. General measures of cognition. Int Psychogeriatr 2003; 15(Suppl 1): 215-217
53. Longstreth WT Jr, Dulberg C, Manolio TA, Lewis MR, Beauchamp NJ Jr, O'Leary D, et al. Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke 2002; 33: 2376-2382
54. Giroud M, Milan C, Beuriat P, Gras P, Essayagh E, Arveux P, et al. Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol 1991; 20: 892-899
55. Gouw AA, van der Flier WM, Pantoni L, Inzitari D, Erkinjuntti T, Wahlund LO, et al. On the etiology of incident brain lacunes: longitudinal observations from the LADIS study. Stroke 2008; 39: 3083-3085
56. Maillard P, Fletcher E, Harvey D, Carmichael O, Reed B, Mungas D, et al. White matter hyperintensity penumbra. Stroke 2011; 42: 1917-1922
57. Jokinen H, Gouw AA, Madureira S, Ylikoski R, van Straaten ECW, van der Flier WM, et al. Incident lacunes influence cognitive decline: the LADIS study. Neurology 2011; 76: 1872-1878
58. Poels MMF, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke 2010; 41: 103-106
59. Poels MMF, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MMB, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke 2011; 42: 656-661
60. Lee S-H, Lee S-T, Kim BJ, Park H-K, Kim C-K, Jung K-H, et al. Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study. PLoS One 2011; 6: e25930
61. Liem MK, Haan J, Van Der Neut IL, Ferrari MD, Van Buchem MA and Van Der Grond J. MRI correlates of cognitive decline in CADASIL. Neurology 2009; 72: 143-148
62. Meier IB, Gu Y, Guzaman VA, Wiegman AF, Schupf N, Manly JJ, et al. Lobar microbleeds are associated with a decline in executive functioning in older adults. Cerebrovasc Dis 2014; 38: 377-383
63. Orken DN, Uysal E, Timer E, Kuloglu-Pazarc N, Mumcu S and Forta H. New cerebral microbleeds in ischemic stroke patients on warfarin treatment: twoyear follow-up. Clin Neurol Neurosurg 2013; 115: 1682-1685
64. Gregoire SM, Smith K, Jäger HR, Benjamin M, Kallis C, Brown MM, et al. Cerebral microbleeds and long-term cognitive outcome: longitudinal cohort study of stroke clinic patients. Cerebrovasc Dis 2012; 33: 430-435
65. Gouw AA, Seewann A, Vrenken H, van der Flier WM, Rozemuller JM, Barkhof F, et al. Heterogeneity of white matter hyperintensities in Alzheimer's disease: postmortem quantitative MRI and neuropathology. Brain 2008; 131: 3286-3298
66. Schmierer K, Altmann DR, Kassim N, Kitzler H, Kerskens CM, Doege CA, et al. Progressive change in primary progressive multiple sclerosis normal-appearing white matter: a serial diffusion magnetic resonance imaging study. Mult Scler 2004; 10: 182-187
67. Shereen A, Nemkul N, Yang D, Adhami F, Dunn RS, Hazen ML, et al. Ex vivo diffusion tensor imaging and neuropathological correlation in a murine model of hypoxia-ischemia-induced thrombotic stroke. J Cereb Blood Flow Metab 2011; 31: 1155-1169
68. Holland PR, Bastin ME, Jansen MA, Merrifield GD, Coltman RB, Scott F, et al. MRI is a sensitive marker of subtle white matter pathology in hypoperfused mice. Neurobiol Aging 2011; 32: 2325.e1-6
69. Schmierer K, Scaravilli F, Altmann DR, Barker GJ and Miller DH. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 2004; 56: 407-415
70. Fazekas F, Ropele S, Enzinger C, Gorani F, Seewann A, Petrovic K, et al. MTI of white matter hyperintensities. Brain 2005; 128: 2926-2932
71. Ropele S, Enzinger C, Söllinger M, Langkammer C, Wallner-Blazek M, Schmidt R, et al. The impact of sex and vascular risk factors on brain tissue changes with aging: magnetization transfer imaging results of the Austrian stroke prevention study. AJNR Am J Neuroradiol 2010; 31: 1297-1301
72. Cavallari M, Moscufo N, Meier D, Skudlarski P, Pearlson GD, White WB, et al. Thalamic fractional anisotropy predicts accrual of cerebral white matter damage in older subjects with small-vessel disease. J Cereb Blood Flow Metab 2014; 34: 1321-1327
73. Auriel E, Edlow BL, Reijmer YD, Fotiadis P, Ramirez-Martinez S, Ni J, et al. Microinfarct disruption of white matter structure: a longitudinal diffusion tensor analysis. Neurology 2014; 83: 182-188
74. Van Norden AGW, de Laat KF, van Dijk EJ, van Uden IWM, van Oudheusden LJB, Gons RAR, et al. Diffusion tensor imaging and cognition in cerebral small vessel disease: the RUN DMC study. Biochim Biophys Acta 2012; 1822: 401-407
75. Van der Holst HM, Tuladhar AM, van Norden AGW, de Laat KF, van Uden IWM, van Oudheusden LJB, et al. Microstructural integrity of the cingulum is related to verbal memory performance in elderly with cerebral small vessel disease: the RUN DMC study. Neuroimage 2013; 65: 416-423
76. Lawrence AJ, Patel B, Morris RG, MacKinnon AD, Rich PM, Barrick TR, et al. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George's cognition and neuroimaging in stroke (SCANS) study. PLoS One 2013; 8: e61014
77. Cavallari M, Ceccarelli A, Wang G-Y, Moscufo N, Hannoun S, Matulis CR, et al. Microstructural changes in the striatum and their impact on motor and neuropsychological performance in patients with multiple sclerosis. PLoS One 2014; 9: e101199
78. Nitkunan A, Barrick TR, Charlton RA, Clark CA and Markus HS. Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time. Stroke 2008; 39: 1999-2005
79. Jokinen H, Schmidt R, Ropele S, Fazekas F, Gouw AA, Barkhof F, et al. Diffusion changes predict cognitive and functional outcome. The LADIS Study. Ann Neurol 2013; 73: 576-583
80. Hong YJ, Yoon B, Lim S-C, Shim YS, Kim J-Y, Ahn KJ, et al. Microstructural changes in the hippocampus and posterior cingulate in mild cognitive impairment and Alzheimer's disease: a diffusion tensor imaging study. Neurol Sci 2013; 34: 1215-1221
81. Teipel SJ, Meindl T, Wagner M, Stieltjes B, Reuter S, Hauenstein K-H, et al. Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis 2010; 22: 507-522
82. Chua TC, Wen W, Slavin MJ and Sachdev PS. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurol 2008; 21: 83-92
83. Dufouil C, Chalmers J, Coskun O, Besancon V, Bousser M-G, Guillon P, et al. Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation 2005; 112: 1644-1650
84. Cavalieri M, Schmidt R, Chen C, Mok V, de Freitas GR, Song S, et al. B Vitamins and MRI-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke: The VITAmins TO Prevent Stroke (VITATOPS) MRI-Substudy. Stroke 2012; 43: 3266-3270
85. Fornage M, Debette S, Bis JC, Schmidt H, Ikram MA, Dufouil C, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol 2011; 69: 928-939
86. Barrick TR, Charlton RA, Clark CA and Markus HS. White matter structural decline in normal ageing: a prospective longitudinal study using tract-based spatial statistics. Neuroimage 2010; 51: 565-577
87. Charlton RA, Schiavone F, Barrick TR, Morris RG and Markus HS. Diffusion tensor imaging detects age related white matter change over a 2 year follow-up which is associated with working memory decline. J Neurol Neurosurg Psychiatry 2010; 81: 13-19
88. Sullivan EV, Rohlfing T and Pfefferbaum A. Longitudinal study of callosal microstructure in the normal adult aging brain using quantitative DTI fiber tracking. Dev Neuropsychol 2010; 35: 233-256
89. Sexton CE, Walhovd KB, Storsve AB, Tamnes CK, Westlye LT, Johansen-Berg H, et al. Accelerated changes in white matter microstructure during aging: a longitudinal diffusion tensor imaging study. J Neurosci 2014; 34: 15425-15436
90. Maniega SM, Valdés Hernández MC, Clayden JD, Royle NA, Murray C, Morris Z, et al. White matter hyperintensities and normal-appearing white matter integrity in the aging brain. Neurobiol Aging 2015; 36: 909-918.